InvestorsHub Logo
icon url

Minnesinger

08/29/18 2:43 PM

#238856 RE: MinnieM #238849

Perhaps it's not unreasonable to believe...

that a partnership could be followed shortly thereafter by a full buyout.

A condition of, say, a B OM partnership, might be first right of refusal on the company as a whole. Once the partner's internal groups (science and M&A) has had ample time to review and assess P 2B results independently, the value proposition might pencil out to take the company out as a whole at this stage of development. LE could negotiate a company sale from the 'partnered price' of the stock, achieving a greater premium for the whole.

Or not.

My thinking relies on the fact Leo has indicated multiple parties are interested in the pipeline for both individual drugs and/or all of the pipeline.

icon url

NanoEngineer

08/29/18 3:53 PM

#238866 RE: MinnieM #238849

Even if there are multiple parties interested, it does not mean that the best offer will be higher than 2 ou 3 times the current market cap which is still quite low given the current depressed SP.

Can someone give me several examples of companies with a market cap of about 100 millions that got bought for more than 2 or 3 times (let's say 10 times) their market cap ?